Works matching IS 15391604 AND DT 2024 AND VI 23 AND IP 1

Results: 9

Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 31, doi. 10.1002/pst.2336

By:

Wang, Guanbo;
Poulin‐Costello, Melanie;
Pang, Herbert;
Zhu, Jiawen;
Helms, Hans‐Joachim;
Reyes‐Rivera, Irmarie;
Platt, Robert W.;
Pang, Menglan;
Koukounari, Artemis

Publication type:

Article

Duration of and time to response in oncology clinical trials from the perspective of the estimand framework.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 91, doi. 10.1002/pst.2340

By:

Weber, Hans‐Jochen;
Corson, Stephen;
Li, Jiang;
Mercier, François;
Roychoudhury, Satrajit;
Sailer, Martin Oliver;
Sun, Steven;
Todd, Alexander;
Yung, Godwin

Publication type:

Article

A conservative approach to leveraging external evidence for effective clinical trial design.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 81, doi. 10.1002/pst.2339

By:

Rigat, Fabio

Publication type:

Article

A marginalized two‐part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancers.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 60, doi. 10.1002/pst.2338

By:

Rustand, Denis;
Briollais, Laurent;
Rondeau, Virginie

Publication type:

Article

Sample size calculation in clinical trials with two co‐primary endpoints including overdispersed count and continuous outcomes.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 46, doi. 10.1002/pst.2337

By:

Homma, Gosuke;
Yoshida, Takuma

Publication type:

Article

Group sequential design with maximin efficiency robust test for immunotherapy with generalized delayed treatment effect.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 107, doi. 10.1002/pst.2341

By:

Li, Bosheng;
Zhang, Jingyi;
Yang, Wenyun;
Su, Liwen;
Yan, Fangrong

Publication type:

Article

Interim decision making in seamless trial designs: An application in an adaptive dose‐finding study in a rare kidney disease.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 20, doi. 10.1002/pst.2335

By:

Papachristofi, Olympia;
Bornkamp, Björn;
Wright, Melanie;
Friede, Tim

Publication type:

Article

Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one‐arm and hybrid control two‐arm trials.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 4, doi. 10.1002/pst.2334

By:

Kopp‐Schneider, Annette;
Wiesenfarth, Manuel;
Held, Leonhard;
Calderazzo, Silvia

Publication type:

Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 1, doi. 10.1002/pst.2307
Publication type:: Article